Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer.
Price: $0.865 | Change: $-0.005 | %Change: -0.57%
Volume: 14,313 | Day High/Low: 0.89/0.86 | 52 Week High/Low: 1.79/0.445
View modes: 
0 stars

Any idea when Phase 2 report out?

If you know or have a guess please let us know. GLTA.  rate and reply
0 stars

RE:RE:Does Brad Suffer from ADD?

good one.loll  rate and reply
0 stars

RE:$1,246,304 or Nothing?

Singing.......great job as usual dissecting this info for us less educated investors......Believe me, i voted alread........ Brad=OUT......and a few others.........Stock option....A BIG more
4.5 stars

$1,246,304 or Nothing?

Has anyone heard anything about the 2014 AGM? I have. The table at the end of this post will tell you the date when it was announced on SEDAR, the date of the meeting and the meeting location. You more
3 stars

crazy aren't we,

only a lil bit  rate and reply
3.5 stars

RE:Does Brad Suffer from ADD?

Just yell B R A D !!!!!!!!!!!!!!!!! bloke  rate and reply
0 stars

Breakout, get in or watch

$$$$$$$$$$$$$$  rate and reply
0 stars


It appears from the latest financials that the cash reserves between March 31 to May 6 9 (five weeks)went up by $0.9 million. Who is pouring money into the company? Can Singing actually be correct? more
5 stars

Does Brad Suffer from ADD?

Does Brad suffer from Attention Deficit Disorder? The last two press releases should make investors wonder. Oncolytics Biotech was founded in 1999. After 15 years, we are still waiting for more
0 stars

May 1 – The AGM Approaches

My End Game targets the AGM as a pressure point for a possible milestone to end collaborative trading practices on the TSX. I’m looking forward to receiving my shareholder material in advance of more
5 stars

ODD Pancreatic

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Status from the EMA for Pancreatic Cancer   04/29/2015   CALGARY, April 29, 2015 /CNW/ - Oncolytics Biotech® more
5 stars

NASDAQ Extension

CALGARY, April 28, 2015 /CNW/ - Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ:ONCY) announced today that it has received a letter from the NASDAQ OMX Group (" more
0 stars

Really Dumb Stock

Said it before.  Tough to figure this one out.  @ $1.70 thought we were out of the woods.  Crazy.  rate and reply
0 stars

Minutes of the EMA meeting

The Committee agreed that the condition, pancreatic cancer, is a distinct medical entity and meets the criteria for orphan designation. The intention to treat the condition with the more
0 stars

RE: Renmark Calgary meeting

Rok1’s summary of the Renmark Calgary meeting is very informative. The two points that stand out for me are the existing 1 million doses of Reolysin and Brad not caring about the potential more
5 stars

Renmark Calgary meeting

I found this on the V2 board. The poster's financial advisor attended the meeting..... Please remember that these are my notes of a discussion between me and my advisor (who attended the more
5 stars

2015 AACR

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting CALGARY, April 20, 2015 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) ( more
0 stars

Orphan Status a two-edged sword

Oncolytics Biotech has a very promising product, and from what I can tell, are still very much in the running if thier funding can hold out until they finish phase III testing.   It seems to me more
5 stars

Oncolytics's Reolysin receives orphan drug designation

It is totally beyond me why the s/p is trading at these incredibly low level....Something must give eventually on the upside.....GLTA   Oncolytics's Reolysin receives orphan drug more
0 stars

RE:FDA ok for Glioma

Results for All Designations Return to Orphan Designation Search Page Row Num Generic Name Designation Date Orphan Designation 1 pelareorep 02-24-2015 Treatment of fallopian tube cancer more